Blood manganese correlates with brain magnetic resonance imaging changes in patients with liver disease

Canadian Journal of Neurological Sciences

Volumn 23, Issue 2, 1996, Pages 95-98

  Hauser, Robert A ^a   Zesiewicz, Theresa A ^a   Martinez, Carlos ^a   Rosemurgy, Alexander S ^a   Olanow, C W ^b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MANGANESE;

ADULT; AGED; ARTICLE; BASAL GANGLION; BLOOD LEVEL; BRAIN DISEASE; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; FEMALE; HEAVY METAL POISONING; HUMAN; LIVER METABOLISM; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSONISM; PRIORITY JOURNAL;

EID: 0029977209     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0317167100038786     Document Type: Article

References (37)

1. Brunberg JA, Kanal E, Hirsch W, Van Thiel DH. Chronic acquired hepatic failure: MR imaging of the brain at 1.5 T. Am J Neuroradiol 1991; 12: 909-914.
2. Inoue E, Shinichi H, Narumi Y, et al. Portal-systemic encephalopathy: presence of basal ganglia lesions with high signal intensity on MR images. Radiology 1991; 179: 551-555.
3. Kulisevsky J, Pujol J, Junque C, et al. MRI pallidal hyperintensity and brain atrophy in cirrhotic patients: two different MRI patterns of clinical deterioration? Neurology 1993; 43: 2570-2573.
4. Young SW. Nuclear Magnetic Resonance Imaging. Basic Principles. New York: Raven Press, 1984.
5. Gomori JM, Grossman RI, Goldberg HI, et al. Intracranial hematomas: imaging by high-field MR. Radiology 1985; 157: 87-93.
6. Gomori JM, Grossman RI, Shields JA, et al. Choroidal melanomas: correlation of NMR spectroscopy and MR imaging. Radiology 1986; 158: 443-445.
7. Dell LA, Brown MS, Orrison WW, Eckel CG, Matwiyoff NA. Physiologic intracranial calcification with hyperintensity on MR imaging: case report and experimental model. Am J Neuroradiol 1988; 9: 1145-1148.
8. Mirowitz SA, Sartor K, Gado M. High-intensity basal ganglia lesions on T1-weighted MR images in neurofibromatosis. Am J Neuroradiol 1989; 10: 1159-1163.
9. Newland MC, Ceckler TL, Kordower JH, Weiss B. Visualizing manganese in the primate basal ganglia with magnetic resonance imaging. Exp Neurol 1989; 106: 251-258.
10. Shinotoh H, Snow B, Hewitt KA, et al. MRI and PET studies of manganese-intoxicated monkeys. Neurology 1995; 45: 1199-1204.
11. Hauser RA, Zesiewicz TA, Rosemurgy AS, Martinez C, Olanow CW. Manganese intoxication and chronic liver failure. Ann Neurol 1994; 36: 871-875.
12. Altman D. Practical Statistics for Medical Research. New York: Chapman and Hall, 1991.
13. Versieck J, Barbler F, Speecke A, Hoste J. Manganese, copper and zinc concentrations in serum and packed blood cells during acute hepatitis, chronic hepatitis and posthepatitic cirrhosis. Clin Chem 1974; 20: 1141-1145.
14. Larsen NA, Pakkenberg H, Damsgaard E, Heydorn K. Topographical distribution of arsenic, manganese, and selenium in the normal human brain. J. Neurol Sci 1979; 42: 407-416.
15. Bonilla E, Salazar E, Joaquin J, et al. The regional distribution of manganese in the normal human brain. Neurochem Res 1982; 7: 221-227.
16. Baruthio F, Guillard O, Arnaud J, Pierre F, Zawislak R. Determination of manganese in biological materials by electrothermal atomic absorption spectroscopy: a review. Clin Chem 1988; 34: 227-234.
17. Greger JL, Davis CD, Suttie JW, Lyle BJ. Intake, serum concentrations and urinary excretion of manganese by adult males. Am J Clin Nutr 1990; 51: 457-461.
18. Greenberg DM, Copp DH, Cuthberston EM. Studies in mineral metabolism with aid of artificial radioactive isotopes; distribution and excretion particularly by way of bile, of iron, cobalt and manganese. J Biol Chem 1943; 147: 749-756.
19. Pollack S, George JN, Reba RC, Kaufmann RM, Crosby WH. The absorption of nonferrous metals in iron deficiency. J Clin Invest 1965; 44: 1470-1473.
20. Klaassen CD. Billiary excretion of manganese in rats, rabbits and dogs. Toxicol Appl Pharmacol 1974; 29: 458-468.
21. Papavasiliou PS, Miller ST, Cotzias GC. Role of liver in regulating distribution and excretion of manganese. Am J Physiol 1966; 211: 211-216.
22. Marchal G, Ni Y, Zhang X, et al. Mn-DPDP enhanced MRI in experimental bile duct obstruction. J Comput Assist Tomography 1993; 17: 290-296.
23. Olanow CW, Calne DB, Chu NS, Perl D. Manganese-induced neurotoxicity. In: Calne DB et al., eds. Advances in Neurodegeneration II, Birkhauser Press, 1994: 53-62.
24. Olanow CW, Good PF, Shinotoh H, et al. Manganese intoxication in the rhesus monkey, a clinical, pathological, and biochemical study. Neurology (In Press).
25. Mirowitz SA, Westrich JJ, Hisch JD. Hyperintense basal ganglia on T1-weighted MR images in patients receiving parenteral nutrition. Radiology 1991; 181: 117-120.
26. Nelson K, Golnick J, Korn T, Angle C. Manganese encephalopathy: utility of early magnetic resonance imaging. Br J Indust Med 1993; 50: 510-513.
27. Mirowitz SA, Westrich TJ. Basal ganglia signal intensity alternations: reversal after discontinuation of parenteral manganese administration. Radiology 1992; 185: 535-536.
28. Watanabe A, Murakami J, Ando T, et al. Reduction of increased signal intensity in the basal ganglia on T1-weighted MR images during treatment of hepatic encephalopathy. Internal Med 1993; 32: 10-14.
29. Mena I, Marin O, Fuenzalida S, Cotzias GC. Chronic manganese poisoning: clinical picture and manganese turnover. Neurology 1967; 17: 128-136.
30. Huang CC, Chu NS, Lu CS, et al. Chronic manganese intoxication. Arch Neurol 1989; 46: 1104-1106.
31. Cook DG, Fahn S, Brait KA. Chronic manganese intoxication. Arch Neurol 1974; 30: 59-64.
32. Huang CC, Lu CS, Chu NS, et al. Progression after chronic manganese exposure. Neurology 1993; 43: 1479-1483.
33. Calne DB, Chu NS, Hung CC, Lu CS, Olanow CW. Manganism and idiopathic parkinsonism: similarities and differences. Neurology 1994; 44: 1583-1586.
34. Sherlock S, Summerskill WHJ, White LP, Phear EA. Portal-systemic encephalopathy: neurological complications of liver disease. Lancet 1954; 267: 453-457.
35. Victor M, Adams RD, Cole M. The acquired (non-Wilsonian) type of chronic hepatocerebral degeneration. Medicine 1965; 44: 345-396.
36. Read AE, Sherlock S, Laidlaw J, Walker JG. The neuro-psychiatric syndromes associated with chronic liver disease and an extensive postal-systemic collateral circulation. Quart J Med 1967; 36: 135-150.
37. Barron TF, Deveny AG, Mamourian AC. Symptomatic manganese neurotoxicity in a patient with chronic liver disease: correlation of clinical symptoms with MRI findings. Ped Neurol 1994; 10: 145-148.